LOTUSEYE

LOTUS EYE HOSPITAL AND INSTITUTE

Small Cap BSE: 532998 NSE: LOTUSEYE
₹69.1
-0.1 (-0.14%)
As on 19 August, 2022 | 07:23

Lotus Eye Hospital And Institute Share Price

Lotus Eye Hospital And Institute Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Lotus Eye Hospital And Institute Share Returns

  • Over 1 Month 39.03%
  • Over 3 Month 32.5%
  • Over 6 Month 18.12%
  • Over 1 Year 55.81%

Lotus Eye Hospital And Institute Key Statistics

P/E Ratio 31.6
PEG Ratio 0.3
Market Cap Cr 144
Price to Book Ratio 2.6
EPS 1.4
Dividend 0.7
Relative Strength Index 54.62
Money Flow Index 61.38
MACD Signal 4.87
Average True Range 6.26

Lotus Eye Hospital And Institute Investment Rating

  • Master Rating:
  • Lotus Eye Hospital And Institute has an operating revenue of Rs. 44.86 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 11% is healthy, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 19% and 26% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -6% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 41 which is a POOR score indicating inconsistency in earnings, a RS Rating of 82 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 79 indicates it belongs to a poor industry group of Medical-Hospitals and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lotus Eye Hospital and Institute Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 12
  • 11
  • 12
  • 11
  • 6
  • 11
  • Operating Expenses Qtr Cr
  • 10
  • 9
  • 9
  • 9
  • 6
  • 9
  • Operating Profit Qtr Cr
  • 2
  • 1
  • 2
  • 2
  • 0
  • 2
  • Depreciation Qtr Cr
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • Interest Qtr Cr
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • Tax Qtr Cr
  • 0
  • 0
  • 1
  • 0
  • 0
  • 0
  • Net Profit Qtr Cr
  • 1
  • 1
  • 1
  • 1
  • 0
  • 1

Lotus Eye Hospital And Institute Technicals

EMA & SMA

Current Price
69.1
-0.1 (-0.14%)
  • Bullish Moving Average
  • ___
  • 10
  • Bearish Moving Average
  • ___
  • 6
  • 20 Day
  • 68.43
  • 50 Day
  • 62.03
  • 100 Day
  • 58.12
  • 200 Day
  • 54.79
  • 20 Day
  • 69.91
  • 50 Day
  • 58.45
  • 100 Day
  • 56.24
  • 200 Day
  • 54.79

Lotus Eye Hospital And Institute Resistance and Support

PIVOT
₹70.39
Resistance
  • First Resistance
  • 71.77
  • Second Resistance
  • 74.34
  • Third Resistance
  • 75.72
Support
  • First Resistance
  • 67.82
  • Second Resistance
  • 66.44
  • Third Resistance
  • 63.87
  • RSI
  • 54.62
  • MFI
  • 61.38
  • MACD Single Line
  • 4.87
  • MACD
  • 3.92

Lotus Eye Hospital And Institute Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 12,993
  • 953,556
  • 73.39
  • Week
  • 42,008
  • 2,927,083
  • 69.68
  • 1 Month
  • 132,149
  • 7,171,726
  • 54.27
  • 6 Month
  • 39,520
  • 2,381,895
  • 60.27

Lotus Eye Hospital And Institute Result Highlights

Lotus Eye Hospital and Institute Synopsis

NSE-Medical-Hospitals

Lotus Eye Hospital belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 32.37 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2021. Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783.
  • Market Cap
  • 144
  • Sales
  • 45
  • Shares in Float
  • 0.87
  • No of funds
  • Yield
  • 0.72
  • Book Value
  • 2.63
  • U/D Vol ratio
  • 1.6
  • LTDebt / Equity
  • 1
  • Alpha
  • 0.2
  • Beta
  • 1.04

Lotus Eye Hospital and Institute

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 57.74%
  • 57.74%
  • 57.74%
  • Individual Investors
  • 27.13%
  • 26.95%
  • 26.23%
  • Others
  • 15.13%
  • 15.31%
  • 16.03%

Lotus Eye Hospital and Institute Management

  • Name
  • Designation
  • Dr. Kavetha Sundaramoorthy
  • Chairman
  • Ms. Sangeetha Sundaramoorthy
  • Managing Director
  • Dr. K S Ramalingam
  • Executive Director & CEO
  • Mr. D R Kaarthikeyan
  • Director
  • Dr. Yogesh Shah
  • Director
  • CA. R Subramanian
  • Director
  • CA. M Alagiriswamy
  • Director
  • Dr. S Natesan
  • Director

Lotus Eye Hospital And Institute Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lotus Eye Hospital And Institute Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-08-09
  • Quarterly Results
  • 2022-05-25
  • Audited Results & Final Dividend
  • 2022-02-14
  • Quarterly Results
  • 2021-11-13
  • Quarterly Results
  • 2021-08-14
  • Quarterly Results

Lotus Eye Hospital and Institute FAQs

What is Share Price of Lotus Eye Hospital and Institute ?

Lotus Eye Hospital and Institute share price is ₹69 As on 19 August, 2022 | 07:09

What is the Market Cap of Lotus Eye Hospital and Institute ?

The Market Cap of Lotus Eye Hospital and Institute is ₹143.7 Cr As on 19 August, 2022 | 07:09

What is the P/E ratio of Lotus Eye Hospital and Institute ?

The P/E ratio of Lotus Eye Hospital and Institute is 31.6 As on 19 August, 2022 | 07:09

What is the PB ratio of Lotus Eye Hospital and Institute ?

The PB ratio of Lotus Eye Hospital and Institute is 2.6 As on 19 August, 2022 | 07:09

Q1FY23